Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
Rev. venez. oncol ; 22(4): 260-264, oct.-dic. 2010. ilus
Article in Spanish | LILACS | ID: lil-574575

ABSTRACT

La leucemia de células dendríticas son patologías poco frecuentes, que involucran fundamentalmente a la piel, pero con una alta tendencia de metástasis. La inmunohistoquímica es una herramienta valiosa junto con la biopsia para el diagnóstico definitivo. Se presenta el caso de una paciente joven, quien acudió por presentar una lesión en la pierna izquierda de dimensiones y características únicas, cuyo diagnóstico requirió de la utilización de marcadores monoclonales específicos en la identificación de esta entidad.


The dendritic cell leukemias are pathologies very uncommon which involve mainly the skin, but with a high tendency of metastasis. The flow cytometric is a valuable tool together with tissue biopsy for a definitive diagnosis. We present the case of a young female who complained for a left leg lesion with unique dimensions and characteristics, in where the diagnostic process required the use of the specific monoclonal markers in the identification of this particular disease.


Subject(s)
Humans , Female , Adult , Antigens, Differentiation/analysis , Dendritic Cells/physiology , Dendritic Cells/pathology , Leukemia/pathology , Leukemia/drug therapy , Leg Injuries , Lymphoma, T-Cell, Cutaneous/pathology , Tobacco Use Disorder/adverse effects , Skin Ulcer/pathology , Skin Ulcer/therapy
2.
Pharmacology ; 68(2): 89-95, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12711836

ABSTRACT

One hundred and sixteen Latin American type 2 diabetic patients previously only on a diet were enrolled in this multicenter, multinational, nonrandomized, noncontrolled study. Only 109 completed the study. After 8 weeks of treatment with 120 mg of nateglinide, administered prior to each meal, the postprandial (2 h) glucose concentration decreased to 85.11 +/- 5.65 mg/dl (p < 0.0001), and HbA(1c) values decreased to 1.06 +/- 0.10% (p < 0.0001). No response differences were detected in relation to age, gender, or ethnicity, but we did encounter a better response in recently diagnosed patients (

Subject(s)
Cyclohexanes/therapeutic use , Diabetes Mellitus, Type 2/drug therapy , Hyperglycemia , Hypoglycemic Agents/therapeutic use , Phenylalanine/therapeutic use , Postprandial Period/drug effects , Blood Glucose/drug effects , Cyclohexanes/adverse effects , Female , Humans , Hyperglycemia/drug therapy , Hyperglycemia/etiology , Hypoglycemic Agents/adverse effects , Latin America , Male , Middle Aged , Nateglinide , Phenylalanine/adverse effects , Phenylalanine/analogs & derivatives , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...